Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46,992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
Jabbour E, Garcia-Manero G, Cortes J, Ravandi F, Plunkett W, Gandhi V, Faderl S, O'Brien S, Borthakur G, Kadia T, Burger J, Konopleva M, Brandt M, Huang X, Kantarjian H. Jabbour E, et al. Among authors: huang x. Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):244-51. doi: 10.1016/j.clml.2012.03.003. Epub 2012 Apr 24. Clin Lymphoma Myeloma Leuk. 2012. PMID: 22534616 Free PMC article. Clinical Trial.
Eradication of minimal residual disease in hairy cell leukemia.
Ravandi F, Jorgensen JL, O'Brien SM, Verstovsek S, Koller CA, Faderl S, Giles FJ, Ferrajoli A, Wierda WG, Odinga S, Huang X, Thomas DA, Freireich EJ, Jones D, Keating MJ, Kantarjian HM. Ravandi F, et al. Among authors: huang x. Blood. 2006 Jun 15;107(12):4658-62. doi: 10.1182/blood-2005-11-4590. Epub 2006 Feb 23. Blood. 2006. PMID: 16497968 Free article. Clinical Trial.
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, Ferrajoli A, Wierda W, Shan J, Davis J, Giles F, Saba HI, Issa JP. Kantarjian H, et al. Among authors: huang x. Blood. 2007 Jan 1;109(1):52-7. doi: 10.1182/blood-2006-05-021162. Epub 2006 Aug 1. Blood. 2007. PMID: 16882708 Free article. Clinical Trial.
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.
Yanada M, Huang X, Garcia-Manero G, O'brien S, Ravandi F, Borthakur G, Faderl S, Issa JP, Kantarjian H, Estey E. Yanada M, et al. Among authors: huang x. Br J Haematol. 2007 Aug;138(4):555-7. doi: 10.1111/j.1365-2141.2007.06670.x. Epub 2007 Jun 25. Br J Haematol. 2007. PMID: 17593249 Free article. No abstract available.
A prognostic score for patients with lower risk myelodysplastic syndrome.
Garcia-Manero G, Shan J, Faderl S, Cortes J, Ravandi F, Borthakur G, Wierda WG, Pierce S, Estey E, Liu J, Huang X, Kantarjian H. Garcia-Manero G, et al. Among authors: huang x. Leukemia. 2008 Mar;22(3):538-43. doi: 10.1038/sj.leu.2405070. Epub 2007 Dec 13. Leukemia. 2008. PMID: 18079733
46,992 results
You have reached the last available page of results. Please see the User Guide for more information.